Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences Fund (JFNSX)

72.71 +0.20 (+0.28%)
At close: 6:45 PM EDT

Performance Overview

Morningstar Return Rating --
YTD Return 10.21%
5y Average Return 11.65%
Number of Years Up 12
Number of Years Down 2
Best 1Y Total Return (Jun 26, 2024) 55.34%
Worst 1Y Total Return (Jun 26, 2024) --
Best 3Y Total Return 55.34%
Worst 3Y Total Return 3.38%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
JFNSX
Category
YTD
7.05%
7.95%
1-Month
3.54%
4.81%
3-Month
0.37%
7.18%
1-Year
14.46%
30.16%
3-Year
5.59%
16.10%
5-Year
12.21%
15.71%
10-Year
11.02%
15.27%
Last Bull Market
25.26%
23.06%
Last Bear Market
-8.35%
-13.88%

Annual Total Return (%) History

Year
JFNSX
Category
2024
--
--
2023
7.10%
--
2022
-3.06%
--
2021
6.41%
--
2020
25.09%
27.63%
2019
28.74%
26.23%
2018
3.96%
-0.40%
2017
22.16%
24.31%

2016
-12.61%
-10.60%
2015
8.01%
8.05%
2014
34.52%
27.25%
2013
55.34%
48.17%
2012
24.35%
21.55%
2011
6.92%
7.66%
2010
7.86%
8.38%
2009
--
22.48%

Past Quarterly Returns

YearQ1Q2Q3Q4
2024 8.47% -- -- --
2023 -1.37% 4.58% -4.20% 8.38%
2022 -5.31% -8.35% -1.96% 13.94%
2021 -2.75% 6.98% -0.94% 3.25%
2020 -13.73% 20.92% 5.18% 13.99%
2019 13.74% 2.11% -6.65% 18.75%
2018 3.67% 5.11% 10.00% -13.27%
2017 11.80% 7.11% 4.16% -2.06%
2016 -13.56% 5.64% 4.31% -8.26%
2015 13.12% 4.33% -12.62% 4.74%

2014 7.14% 6.07% 7.15% 10.47%
2013 14.64% 5.80% 16.41% 10.02%
2012 15.08% -0.28% 8.60% -0.22%
2011 6.92% 6.07% -13.61% 9.14%
2010 4.00% -12.06% 12.25% 5.08%
2009 5.69% -- -- --

Rank in Category (By Total Return)

YTD 10
1-Month 25
3-Month 26
1-Year 15
3-Year 9
5-Year 9

Load Adjusted Returns

1-Year 14.46%
3-Year 5.59%
5-Year 12.21%
10-Year 11.02%

Performance & Risk

YTD Return 10.21%
5y Average Return 11.65%
Rank in Category (ytd) 10
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.75
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Janus Henderson
Net Assets 5.26B
YTD Return 7.05%
Yield 0.00%
Morningstar Rating
Inception Date Jul 06, 2009

Fund Summary

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Related Tickers